INHIBRX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.24 USD | -3.85% |
|
-52.39% | -57.26% |
| 04/06 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
| 31/05 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INHIBRX, INC. | Bio Therapeutic Drugs | -3.85% | -52.39% | -57.26% | -34.14% | - | 1.79B |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- INBX Stock
- Charts Inhibrx, Inc.
- Comparison Chart
